EpiCept Corporation

New Jersey, United States



EpiCept Corporation, New Jersey, United States

Specialty pharmaceutical company with a proprietary technology for the topical delivery of prescription medications for the treatment of pain.


Evaluate strategic alternatives

Our Role

Retained advisor to the Board of Directors and management

  • Attended Board meetings in person or via conference call.
  • Assisted management in contacting and evaluating potential underwriters to support an initial public offering.
  • Organized investment banking ‘bake-off’ with interested underwriters.
  • Guided management in selecting a lead underwriter and two co-managers.
  • Assisted management in negotiating syndicate economics and underwriting agreement.
  • Facilitated contact to the Board of Maxim Pharmaceuticals, Inc., when initial public offering was pulled due to market conditions.
  • Consulted management and the Board on a reverse merger of the Company into Maxim Pharmaceuticals, Inc.

N.B. Consulting services performed prior to the formation of CATALYSIS CAPITAL PARTNERS LTD. and authorisation and regulation by FCA UK